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Abstract
Guanosine 3P,5P-cyclic monophosphate (cGMP) has been recently reported to be involved in bone formation. ATDC5 cells
were used to investigate cGMP metabolism during chondrogenic differentiation. Natriuretic peptide receptor (NPR)-A and
NPR-B coupled with guanylate cyclase (GC) mediate biological functions of NPs, whereas NPR-C uncoupled with GC is
thought to be the clearance receptor for NPs. The amounts of NPR-A, NPR-B, and CNP transcripts were increased but the
amount of NPR-C transcripts was decreased in association with the chondrogenic differentiation of ATDC5 cells. CNP, a
specific ligand for NPR-B lets ATDC5 cells accumulate great amounts of cGMP, revealing NPR-B as a dominant biological
receptor through differentiation. cGMP hydrolytic activities of PDE1 and PDE5 existed in ATDC5 cells, and the activity of
PDE1, which is stimulated by Ca2 and calmodulin (CaM) was major of them. Total cGMP hydrolytic activities as well as
the amounts of PDE1 and PDE5 transcripts were enhanced during chondrogenic differentiation. Therefore, cGMP
production and hydrolysis, cGMP metabolism was considered to be activated in association with chondrogenic
differentiation of ATDC5 cells. These observations may lead to a better understanding of cGMP in the chondrocytes
where bone formation occurs. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Guanosine 3P,5P-cyclic monophosphate (cGMP) is
involved in many physiological functions, such as
smooth muscle relaxation, retinal phototransduction,
and intestinal secretion. Intracellular cGMP levels
are regulated by guanylate cyclases (GCs) and phos-
phodiesterases (PDEs). GCs produce cGMP in re-
sponse to natriuretic peptides (NPs) and nitric oxide,
whereas PDEs hydrolyze cGMP and cAMP.
NPs act as potent regulators in cardiovascular ho-
meostasis through their function such as vasorelaxa-
tion, diuresis, and natriuresis [1^3]. The peptides
form a family of at least three polypeptide hor-
mones: atrial-NP (ANP), brain-NP (BNP), and C-
type-NP (CNP) [4,5]. The biological e¡ects of these
peptides are mediated through membrane-bound re-
ceptors (NP receptor (NPR)-A and NPR-B). These
receptors are glycoproteins of V120 kDa with GC
[6,7]. ANP is a selective ligand for NPR-A, and CNP
possesses the highest a⁄nity for NPR-B but the low-
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est a⁄nity for NPR-A [8]. Although BNP binds to
NPR-A rather than to NPR-B, the selective receptor
for BNP has not been identi¢ed. On the other hand,
NPR-C, a homodimer of V70 kDa, has a shorter
intracellular tail lacking the cyclase domain and is
therefore uncoupled from cGMP [9,10]. NPR-C has
a very high selectivity for all members of the NP
family [8]. Because NPR-C is the most abundant
NPR in the tissues and cells that receive a large
fraction of the cardiac output, including vascular en-
dothelial [11] and smooth muscle cells [12], the ex-
pected function of NPR-C was thought to remove
NPs from the blood circulation by binding and in-
ternalization [13].
Intracellular cGMP is metabolized by many kinds
of PDEs. PDEs possessing cGMP hydrolytic activity
have been classi¢ed based on their amino acid se-
quence homology, biochemical properties, and inhib-
itor pro¢les [14,15]. PDE1 is Ca2/calmodulin-de-
pendent, hydrolyzing both cAMP and cGMP.
PDE2 is stimulated by cGMP and hydrolyzes
cAMP and cGMP. PDE5 is a cGMP-speci¢c PDE.
PDE6 is a photoreceptor cGMP PDE. PDE9, which
was recently identi¢ed [16,17], is a cGMP PDE and
insensitive to a nonspeci¢c PDE inhibitor, 3-isobutyl-
1-methylxanthine (IBMX). Recently, we identi¢ed a
novel PDE: PDE10, which is a cAMP and a cAMP-
inhibited cGMP PDE [18].
Longitudinal bone formation occurs through the
endochondral ossi¢cation, that is chondrocytes dif-
ferentiate sequentially from the proliferating stage
to the hypertrophic stage, next to the calci¢ed stage,
and then are replaced by osteoblasts at the growth
plate. Several lines of evidence have suggested that
NPs may be involved in bone formation. For in-
stance, cGMP produced in response to ANP and
CNP inhibits the proliferation and promotes the dif-
ferentiation of osteoblast-like cells from newborn rat
calvaria [19]. CNP is also a stimulator of the di¡er-
entiation of clonal osteoblastic MC3T3-E1 cells [20].
Moreover, involvement of cGMP in bone formation
was reported using knockout and transgenic mice.
Mice de¢cient in the cGMP-dependent protein kin-
ase II show dwar¢sm caused by a defect in endo-
chondral ossi¢cation at the growth plate [21]. The
heights of both proliferating and hypertrophic zones
of the growth plate cartilage are increased in trans-
genic mice that overexpress BNP [22]. Thus, NPs and
their second messenger cGMP is expected to be one
of key factors in bone formation.
Chondrocytes in three di¡erentiating stages, such
as the proliferative, hypertrophic, and calci¢ed
stages, exist at the growth plate. The calci¢ed chon-
drocytes are replaced by osteoblasts, resulting in the
endochondral bone formation. The clonal mouse em-
bryonic cell line ATDC5 cells keep track of the mul-
tistep di¡erentiation process from chondroprogenitor
mesenchymal cells to calci¢ed chondrocytes [23,24].
On the other hand, only terminal di¡erentiation,
which is from proliferating cells to hypertrophic
and calci¢ed cells, can be observed in the primary
chondrocyte culture. Therefore, ATDC5 cells are
considered suitable for the analysis of initial di¡er-
entiation, that is, from mesenchymal cells to prolif-
erating chondrocytes. We demonstrated that the ex-
pression of NPR-C is decreased in association with
initial chondrogenic di¡erentiation of the rat carti-
lage and of ATDC5 cells in a previous study [25].
In the present study, we have focused on the alter-
ation of cGMP production and hydrolysis during
initial chondrogenic di¡erentiation using ATDC5
cells. These studies have suggested that cGMP me-
tabolism may become more active in the di¡erenti-
ated ATDC5 cells and it perhaps also in the chon-
drocytes.
2. Materials and methods
2.1. Materials
[K-32P]dCTP and Hybond-N+nylon membrane
were from Amersham Pharmacia Biotech. The plas-
mid pGEM-T was a product of Promega. Rat ANP
and CNP-22 were purchased from Peptide Institute
(Osaka, Japan). Mouse BNP-45 was obtained from
Peninsula Laboratories. E4021 was synthesized at
Tanabe Seiyaku Co. (Osaka, Japan).
2.2. Cell cultures
The clonal mouse embryonic cell line ATDC5 was
obtained from Riken Gene Bank (Ibaraki, Japan)
and was cultured in maintenance medium (a 1:1 mix-
ture of Dulbecco’s modi¢ed Eagle’s and Ham’s F-12
medium, 5% fetal calf serum; Gibco BRL) and in
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di¡erentiation medium (maintenance medium supple-
mented with 10 Wg/ml bovine insulin; Wako Pure
Chemical, Osaka, Japan) to induce di¡erentiation
of the cells. ATDC5 cells were maintained in a con-
trolled atmosphere of 5% CO2/95% air at 37‡C.
2.3. Reverse transcriptase^polymerase chain reaction
(RT^PCR) analysis
The RT reaction was performed using mRNAs
from ATDC5 cells to identify expression of di¡er-
entiated marker (type II collagen) transcripts. RT
was carried out using random hexamers and 1 Wg
of mRNA as a template at 42‡C for 60 min accord-
ing to the manufacturer’s instruction of GeneAmp
RNA PCR Core kit (PE Applied Biosystems). Sense
and antisense primers for PCR were prepared as de-
scribed previously [26]. PCR was carried out through
20 cycles of denaturation at 94‡C for 1 min, anneal-
ing at 55‡C for 2 min, and extension at 72‡C for
2 min, under conditions that each PCR did not reach
saturation. Mouse L-actin transcripts were also de-
tected by RT^PCR as a control for the RNA quan-
tity among di¡erent samples. L-Actin cDNA frag-




PDE1A, PDE1B, and PDE1C transcripts were in-
vestigated by RT^PCR under di¡erent conditions.
RT was under the same condition as described above
and PCR was carried out through 30 cycles of dena-
turation at 94‡C for 30 s, annealing at 55‡C for 30 s,
and extension at 72‡C for 1 min. Speci¢c primer sets
were designed based on the nucleotide sequences of
PDE1A [27], PDE1B [28], and PDE1C [29]. These
cDNA fragments were ampli¢ed by PCR using
each primer set: (5P-ATGATGAAAAAGAAGC-
CTG-3P plus 5P-GCATGATACCTGTAGGAAGC-
3P) for PDE1A, (5P-CAGCAGACCCGAGCCAA-
AGG-3P plus 5P-CTGTGCGGAGAAGGAAGC-3P)
for PDE1B, and (5P-ATGCTTAGGAGAAGTG-
ATG-3P plus 5P-CCTGTCTTATAAAGGAGG-3P)
for PDE1C.
2.4. Northern blot analysis
ATDC5 cells were cultured in a maintenance me-
dium for 4 days and in di¡erentiation medium for
20 days. Total RNAs were isolated from the cells by
ISOGEN (Nippon Gene, Japan) and mRNA was
puri¢ed using an mRNA separator kit (Clontech).
mRNAs were subjected to electrophoresis in 1%
agarose/0.66 M formaldehyde gels. The blots were
transferred onto Hybond-N+nylon membrane and
¢xed by ultraviolet irradiation using a UV cross-link-
er (Stratagene). DNA probes for the hybridization
analysis were obtained by RT^PCR using mRNAs
from mouse lung or ATDC5 cells as a template
and sense and antisense primers designed based on
the nucleotide sequences of NPR-A [30] and NPR-B
[7,31]. The cDNA fragments encoding a part of





PCR was carried out through 30 cycles of denatura-
tion at 94‡C for 1 min, annealing at 55‡C for 2 min,
and extension at 72‡C for 2 min. The ampli¢ed frag-
ments were subcloned into pGEM-T easy and their
nucleotide sequences were con¢rmed by the dideoxy-
chain-termination method, using an Applied Biosys-
tems model 373A automated sequencer and a dye
primer cycle sequencing kit (PE Applied Biosystems).
32P-Labeled DNA probes were prepared using a ran-
dom primer labeling kit (Takara Shuzo, Japan). The
probe for NPR-C was prepared as described previ-
ously [32]. The probe for PDE5 was obtained by
RT^PCR using the mouse lung cDNA library (Clon-
tech) as described previously [33]. Hybridization was
performed in 50% formamide, 5USSC, 0.5% SDS,
5UDenhardt’s, 100 Wg/ml salmon sperm DNA, and
the probe at 42‡C for 16 h. All blots were washed
¢nally in 0.2USSC and 0.1% SDS at 60‡C for 30 min.
The membranes were exposed to X-ray ¢lms at
370‡C. The resultant X-ray ¢lms were scanned by
ScanJet 4c (Hewlett Packard) and DeskScan II pro-
gram, and quantitated using the NIH Image pro-
gram.
2.5. Measurements of the accumulation of
intracellular cGMP
ATDC5 cells cultured for 4 days in maintenance
medium in 12-well plates and for 20 days in di¡er-
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entiation medium in 24-well plates were washed twice
with PBS. Then, the cells were incubated in mainte-
nance medium containing 0.1% BSA instead of 5%
FCS, 0.5 mM IBMX, and one of three NPs for 30
min. After incubation, the cells were washed twice
with PBS and intracellular cGMP were eluted in
50% ethanol. The elution was dried up and then
cGMP contents were measured using the cGMP,
Biotrak enzyme immunoassay system (Amersham
Pharmacia Biotech).
2.6. RT^PCR and Southern blot analysis
To detect CNP-22 transcripts in the undi¡erenti-
ated and the di¡erentiated ATDC5 cells, RT^PCR
was performed using 1 Wg of mRNA prepared
from the cells. Sense and antisense primers were de-
signed based on the nucleotide sequences [34]. The
cDNA fragments encoding a part of CNP were pro-
duced using the speci¢c primer sets 5P-CACCATG-
CACCTCTCCCAGC-3P plus 5P-ATGGAGCCGA-
TCCGGTCCAG-3P. PCR was carried out through
30 cycles of denaturation at 94‡C for 1 min, anneal-
ing at 55‡C for 2 min, and extension at 72‡C for
2 min. The RT^PCR products were subjected to
2% agarose gel electrophoresis, then the DNA frac-
tions were transferred onto Hybond-N+nylon mem-
brane. The blots were ¢xed by ultraviolet irradiation.
To detect PCR products by Southern blot analysis,
32P-labeled oligonucleotide probes homologous to a
part of CNP-22 sequence, which do not contain the
primer sequences for RT^PCR mentioned above,
were prepared. Their nucleotide sequences are 5P-
ACCACCGAAGTCCCGAGAAC-3P for CNP. Hy-
bridization was performed in 6USSC, 0.5% SDS,
5UDenhardt’s, 100 Wg/ml salmon sperm DNA, and
the 32P-labeled probe at 65‡C for 16 h. All blots were
washed ¢nally in 1USSC and 0.1% SDS at 50‡C for
20 min. The membranes were exposed to X-ray ¢lm
at 370‡C.
2.7. DEAE^Sepharose chromatography
ATDC5 cells were cultured for 4 days in mainte-
nance medium and for 20 days in di¡erentiation me-
dium. 6U107 cells each were used for the following
experiments. The cells were washed with PBS twice
and incubated in collagenase solution (1 mg/ml) for
15 min at 37‡C. The cells were scraped and washed
with PBS again. The collected cells were disrupted in
ice-cold homogenization bu¡er (20 mM Tris^HCl
(pH 7.5), 2 mM Mg acetate, 0.3 mM CaCl2, 1 mM
dithiothreitol, 40 WM leupeptin, 1.3 mM benzami-
dine, 0.2 mM phenylmethylsulfonyl£uoride, and
1 mM NaN3) by a sonicator (TOMY Seiko, Japan)
for 15 s (three times with 1-min intervals) and homo-
genates were centrifuged at 100 000Ug for 60 min.
The resultant supernatants were applied to a DEAE^
Sepharose column (Amersham Pharmacia Biotech)
equilibrated in elution bu¡er (20 mM Tris^HCl
(pH 7.5), 1 mM dithiothreitol, 1 mM CaCl2, 2 WM
leupeptin, and 5 mM benzamidine). The column was
washed with 10 ml of elution bu¡er, and the proteins
were then eluted from the column by running a linear
NaCl gradient (0^1000 mM, 50 ml) in elution bu¡er.
Fractions (1 ml each) were collected on ice and as-
sayed for PDE activity.
2.8. PDE assay
The PDE assay was performed by the radiolabeled
nucleotide method [35]. The assay bu¡er contained
50 mM Tris^HCl (pH 8.0), 5 mM MgCl2, 4 mM
2-mercaptoethanol, either 1 WM unlabeled cGMP
or cAMP, and either 22 nM [3H]cGMP or
[3H]cAMP. In order to observe the activation of
cGMP hydrolytic activity, either 1 mM EGTA or
20 U CaM and 2 mM CaCl2 was added to the assay
bu¡er. All assays were performed for 30 min at 37‡C.
After boiling for 1.5 min, the mixtures were added by
100 Wl of 1 mg/ml solution of Crotalus atrox snake
venom and incubated for 30 min at 37‡C. The reac-
tion was stopped by the addition of 500 Wl of meth-
anol and then resultant solutions were applied to a
Dowex (1U8^400) column. Aqueous scintillation
cocktails were added to each elute and counted.
3. Results
3.1. Induction of chondrogenic di¡erentiation of
ATDC5 cells
ATDC5 cells retain the properties of chondropro-
genitor cells [23]. The proliferation of ATDC5 cells
as well as other cell lines halts at the con£uent stage.
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However, the proliferation restarts in the presence of
insulin and then chondrogenic di¡erentiation occurs
through a cellular condensation process, resulting in
the formation of cartilage nodule like cell aggregates
[23]. In order to know the alteration of cGMP me-
tabolism during chondrogenesis, chondrogenic di¡er-
entiation of ATDC5 cells was induced. ATDC5 cells
were cultured for 4 days in maintenance medium and
for 20 days in di¡erentiation medium. Type II colla-
gen is known as the cartilage-characteristic extracel-
lular matrix, and the amounts of this transcripts be-
come higher in the di¡erentiated cells [26]. Type II
collagen and L-actin transcripts in ATDC5 cells were
analyzed by the RT^PCR method as a di¡erentiation
marker and a control for mRNA quantities, respec-
tively (Fig. 1). Although type II collagen transcripts
were barely detectable on day 4, they became easily
detectable on day 20. Because the amounts of L-actin
transcripts were unchanged, chondrogenic di¡eren-
tiation was certainly induced in ATDC5 cells cul-
tured for 20 days in di¡erentiation medium.
3.2. Expression of the NPR transcripts during
chondrogenesis of ATDC5 cells
Northern blot analysis was performed using
mRNAs isolated from ATDC5 cells on day 4 and
on day 20 to investigate expression patterns of
NPR transcripts during chondrogenic di¡erentiation
(Fig. 2). The amount of NPR-A transcripts was in-
creased from undetectable to barely detectable level.
NPR-B transcripts were already detectable on day 4
and were produced to a greater extent on day 20.
The increase was approximately 9-fold. On the con-
trary, the amount of NPR-C transcripts was de-
creased by half on day 20. From these observations,
intracellular cGMP production through the NP sys-
Fig. 3. Intracellular cGMP accumulation in the undi¡erentiated
and the di¡erentiated ATDC5 cells. ATDC5 cells cultured for
4 days (A) and for 20 days (B) were exposed to various concen-
trations of ANP (squares), BNP (triangles), and CNP (circles)
for 30 min. Intracellular cGMP contents were measured. Data
points and bars represent mean þ S.E. (n = 3).
Fig. 2. Expression of the NPR transcripts during chondrogenic
di¡erentiation of ATDC5 cells. Northern blot analysis was per-
formed using mRNAs isolated from ATDC5 cells on day 4
(lane 1) and day 20 (lane 2). mRNAs (2 Wg/lane) were subjected
to 1% agarose/0.66 M formamide gel and transferred onto the
membrane. The blots were hybridized with 32P-labeled DNA
fragments encoding a part of NPR-A, NPR-B, NPR-C, and L-
actin.
Fig. 1. Induction of type II collagen transcripts in the di¡erenti-
ated ATDC5 cells. mRNAs were isolated from ATDC5 cells on
day 4 (lane 1) and day 20 (lane 2). One Wg of mRNAs was
used for RT^PCR analysis. PCR was carried out through
20 cycles with primer sets for type II collagen and L-actin.
PCR products were subjected to 4% polyacrylamide gel and the
gel was stained with ethidium bromide.
BBAMCR 14564 26-11-99
K. Fujishige et al. / Biochimica et Biophysica Acta 1452 (1999) 219^227 223
tem was considered to be enhanced in the di¡erenti-
ated ATDC5 cells.
3.3. Intracellular cGMP accumulation by NPs
The amounts of intracellular cGMP by NP stim-
ulation were measured in ATDC5 cells to compare
the contribution of NPR-A to cGMP production
with that of NPR-B. In the undi¡erentiated cells
(Fig. 3A), CNP-22 was the most potent stimulator
and approximately 240-fold higher intracellular
cGMP over the basal level was accumulated by stim-
ulation of 1037 M of CNP-22. By contrast, increase
of cGMP levels by stimulation of 1037 M of ANP
and BNP-45 was only 20- and 12-fold, respectively.
In the di¡erentiated cells (Fig. 3B), CNP-22 was also
more potent than other two peptides. 1037 M of
ANP, BNP-45 and CNP-22 showed increase of ap-
proximately 5-, 20-, and 390-fold intracellular cGMP
over the basal level, respectively. These results dem-
onstrated that NPR-B is a dominant biological re-
ceptor through the di¡erentiation of ATDC5 cells.
3.4. Expression of CNP transcripts during
chondrogenesis of ATDC5 cells
Expression of CNP transcripts was examined in
ATDC5 cells. Because the transcripts could not be
detected in Northern blot analysis, we employed a
combination of RT^PCR and Southern blot analysis
(Fig. 4). To distinguish between RT^PCR products
from mRNA and PCR products from contaminated
genomic DNA, speci¢c primers designed to span a
genomic intron were used for PCR. The predicted
RT^PCR products are 366 bp for CNP in length.
RT^PCR products from mRNA and the PCR prod-
ucts from contaminated genomic DNA can be rec-
ognized as di¡erent bands by 2% agarose gel electro-
phoresis. Although RT^PCR products from CNP
transcripts were undetectable in the undi¡erentiated
Fig. 5. Elution pro¢le of DEAE^Sepharose chromatography of
cytosolic extracts of ATDC5 cells. The cytosolic extracts of the
undi¡erentiated ATDC5 cells on day 4 (A) and the di¡erenti-
ated cells on day 20 (B) were loaded onto a DEAE^Sepharose
column and eluted with bu¡ers containing 0^1 M NaCl. Each
fraction was used for the assay of PDE activity. One WM
cGMP or cAMP was used as a substrate. Circles represent the
cGMP hydrolytic activity in the presence of Ca2/CaM (open)
and EGTA (closed). Squares represent the cAMP hydrolytic ac-
tivity in the absence (open) and presence (closed) of cGMP.
Fig. 4. Detection of CNP transcripts by RT^PCR and Southern
blot analysis. mRNAs prepared from ATDC5 cells on day 4
(lane 1) and day 20 (lane 2) were used for RT^PCR analysis.
PCR was carried out through 30 cycles with a primer set for
CNP. The RT^PCR products derived from mRNAs were sub-
jected to Southern blot analysis using 32P-labeled oligonucleo-
tides homologous to a part of nucleotide sequences of CNP.
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cells, they were increased to be detectable in the dif-
ferentiated cells. Therefore, CNP transcripts were re-
vealed to be mainly expressed in the di¡erentiated
cells, and cGMP may be produced by autocrine reg-
ulation in the di¡erentiated cells.
3.5. Properties of cGMP PDEs in ATDC5 cells
DEAE^Sepharose column chromatography was
carried out to investigate which kinds of cGMP
PDEs are present in ATDC5 cells. The cytosolic ex-
tract of the undi¡erentiated cells displayed PDE5
and PDE1 activities resolved by DEAE^Sepharose
column chromatography (Fig. 5A). Fractions 21^24
hydrolyzed cGMP with a high degree of selectivity
and the cGMP hydrolytic activities were not stimu-
lated by the addition of Ca2/CaM. E4021, which is
a PDE5-speci¢c inhibitor, inhibited the activities
with IC50 of 11 nM. By contrast, the cGMP hydro-
lytic activities of fractions 29^38 were stimulated by
Ca2/CaM. Therefore, we considered that fractions
21^24 and fractions 29^38 corresponded to PDE5
and PDE1, respectively. The cAMP hydrolytic activ-
ity was not stimulated by cGMP. Thus, PDE2 activ-
ity was not detected in the cells. The cytosolic extract
of the di¡erentiated cells displayed also PDE5 and
PDE1 activities but not PDE2 activity (Fig. 5B).
Fractions 21^24 and fractions 25^44 corresponded
to PDE5 and PDE1 as in the case of the undi¡eren-
tiated cells mentioned above. Total cGMP hydrolytic
activities were apparently increased in the di¡erenti-
ated cells. These ¢ndings indicated that cGMP hy-
drolytic activities of PDEs were enhanced during
chondrogenic di¡erentiation of ATDC5 cells.
3.6. Expression of PDE1 and PDE5 transcripts
during chondrogenesis of ATDC5 cells
PDE5 transcripts were detected by Northern blot
analysis (Fig. 6A). Their amount was increased dur-
ing chondrogenic di¡erentiation. PDE1 transcripts
were detected by RT^PCR analysis (Fig. 6B). Three
isoforms of the PDE1 family, PDE1A, PDE1B, and
PDE1C, are reported. Speci¢c PCR primers for each
PDE1 isozyme were designed and RT^PCR analysis
was performed. The length of ampli¢ed DNA frag-
ments and their nucleotide sequence agreed with
those predicted. The levels of transcripts encoding
these PDEs were revealed to be elevated during
chondrogenic di¡erentiation. Therefore, the amounts
of PDE1 and PDE5 transcripts were augmented, as
was their cGMP hydrolytic activities in the di¡eren-
tiated cells.
4. Discussion
In the previous study, we demonstrated that the
Fig. 6. Expression of cGMP PDE transcripts during chondrogenic di¡erentiation of ATDC5 cells. Northern blot analysis was per-
formed as described in Fig. 2A. mRNAs isolated from ATDC5 cells on day 4 (lane 1) and on day 20 (lane 2) were subjected to 1%
agarose/0.66 M formamide gel and transferred onto the membrane. The blots were hybridized with 32P-labeled DNA fragments encod-
ing a part of PDE5. One Wg of mRNAs was used for RT^PCR analysis (B). PCR was carried out through 30 cycles with primer sets
for PDE1A, PDE1B, and PDE1C. PCR products were subjected to 4% polyacrylamide gel and the gel was stained with ethidium bro-
mide.
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amounts of the NPR-C protein are decreased in as-
sociation with the initial di¡erentiation of ATDC5
cells. This suggests the involvement of NP regulation
leading to control of cGMP production on chondro-
genic di¡erentiation. We have investigated the alter-
ation of cGMP metabolism including cGMP produc-
tion by NP system and cGMP hydrolysis by PDEs
during chondrogenic di¡erentiation of ATDC5 cells.
Interesting changes are reduction of the level of
NPR-C transcripts as well as that of the NPR-C
protein, and increases of the levels of GC-coupled
receptors and CNP transcripts during di¡erentiation.
NPR-C lacking GC activity regulates the biological
e¡ects by eliminating NPs. Therefore, in the di¡er-
entiated cells, a larger amount of cGMP may be
produced by autocrine or paracrine regulation. NPs
are known to inhibit the proliferation and to pro-
mote the di¡erentiation of osteoblast-like cells via
cGMP production [19]. Thus, cGMP produced in
the di¡erentiated ATDC5 cells may inhibit the pro-
liferation and promote the next di¡erentiation, ter-
minal di¡erentiation. On the other hand, NPR-C was
reported to be expressed in the osteoblastic cells, and
mice de¢cient in NPR-C showed skeletal deformities
associated with a considerable increase in bone turn-
over [36]. These results suggested that NPR-C may
have a signaling function of its own in osteoblastic
cells and may play a role on bone formation.
CNP that is a speci¢c ligand for NPR-B lets the
cells accumulate a great deal of intracellular cGMP
in contrast to other NPs both in the undi¡erentiated
and in the di¡erentiated ATDC5 cells. Thus, the
CNP/GC-B pathway was considered to be physiolog-
ically signi¢cant in ATDC5 cells, in primary chon-
drocytes, and in an organ culture of tibias [19,37].
The undi¡erentiated ATDC5 cells were equipped
with the CNP/GC-B pathway, suggesting that the
pathway may be present in chondroprogenitor cells
in vivo.
cGMP hydrolytic activities in the cytosolic extract
of ATDC5 cells were separated by DEAE^Sepharose
column chromatography, resulting in two peaks both
in the undi¡erentiated cells and in the di¡erentiated
cells. A minor peak is derived from PDE5 and a
major peak from PDE1. The cytosolic extracts of
MC3T3-E1 cells that have osteoblastic properties
and cause osteoblastic di¡erentiation also yield
cGMP hydrolytic activity of PDE1 (unpublished
data). ATDC5 cells and MC3T3-E1 cells di¡erentiate
during culture and are often used for the study of
endochondral bone formation. It is intriguing that
cGMP hydrolytic activity that is regulated by Ca2/
calmodulin was displayed in those cells, suggesting
the involvement of the controllable cGMP hydrolytic
activity in di¡erentiation. Three isozymes, PDE1A,
PDE1B, and PDE1C, are present in the PDE1 fam-
ily. Expression of PDE1C is speci¢cally induced
when smooth muscle cells dedi¡erentiate to the pro-
liferative cells [38]. In ATDC5 cells, however, the
three PDE1 isozyme transcripts were produced in
higher amounts during di¡erentiation, and speci¢c
change of PDE1C expression in association with dif-
ferentiation was not observed.
Total cGMP hydrolytic activities were augmented
during chondrogenic di¡erentiation of ATDC5 cells.
Because cGMP is known to be toxic against the cells
[39] in addition to promoting di¡erentiation, it is
likely that increased cGMP-hydrolytic activities func-
tion to degrade cGMP after a cGMP-mediated signal
has been transduced. On the other hand, cAMP hy-
drolytic activities which did not overlap with cGMP
hydrolytic activities were shown in fractions 35^45
(Fig. 5). The cAMP hydrolytic activities are probably
derived from PDE4 and/or PDE7 (cAMP-speci¢c
PDEs), but not PDE1. Thus, these cAMP-speci¢c
PDEs may hydrolyze cAMP in cooperation with
PDE1 in ATDC5 cells.
Although involvement of cAMP in chondrogenic
di¡erentiation has been investigated in many reports,
few reports concerning cGMP are available. We have
demonstrated the alteration of cGMP metabolism
during chondrogenic di¡erentiation of ATDC5 cells.
These results suggest involvement of cGMP-medi-
ated signal transduction in initial chondrogenic dif-
ferentiation. Further investigations will elucidate the
physiological functions of cGMP in endochondral
bone formation.
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